Activity of taspine isolated from Radix et Rhizoma Leonticis against estrogen-receptor-positive breast cancer

Fitoterapia

Volumn 82, Issue 6, 2011, Pages 896-902

  Zhan, Yingzhuan ^a   Zhang, Yanmin ^a   Chen, Yinnan ^a   Wang, Nan ^a   Zheng, Lei ^a   He, Langchong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Estrogen receptor; Estrogen receptor positive breast cancer; Progesterone receptor; Taspine

Indexed keywords

BETA ACTIN; ESTROGEN RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PROGESTERONE RECEPTOR; TASPINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER TISSUE; CELL CYCLE; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LEONTICIS RADIX; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHIZOME; STRUCTURE ACTIVITY RELATION; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ALKALOIDS; ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; DRUGS, CHINESE HERBAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER;

MUS;

EID: 79960084925     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2011.05.004     Document Type: Article

References (42)

1. L.A. Niemeier, D.J. Dabbs, S. Beriwal, J.M. Striebel, and R. Bhargava Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation Modern Pathol 23 2010 205 212
2. Y.M. Zhang, L.C. He, and M. Liang Suppression of tumor-induced angiogenesis by taspine isolated from Radix et Rhizoma Leonticis and its mechanism of action in vitro Cancer Lett 262 2008 103 113
3. J.R. Harris, M.E. Lippman, U. Veronesi, and W. Willett Breast cancer (3) N Engl J Med 327 1992 473 480
4. K.I. Pritchard Ovarian ablation as adjuvant therapy for early-stage breast cancer Cancer Treat Res 94 1998 158 180
5. Early Breast Cancer Trialists' Collaborative Group Tamoxifen for early breast cancer: an overview of the randomized trials Lancet 351 1998 1451 1467
6. M. Baum, A.U. Budzar, J. Cuzick, J. Forbes, J.H. Houghton, and J.G. Klijn Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial Lancet 359 2002 2131 2139 (Pubitemid 34694019)
7. A. Howell, C.K. Osborne, C. Morris, and A.E. Wakeling ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen Cancer 89 2000 817 825 (Pubitemid 30658581)
8. J.F. Robertson, R.I. Nicholson, N.J. Bundred, E. Anderson, Z. Rayter, and M. Dowsett Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)- nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer Cancer Res 6 2001 6739 6746 (Pubitemid 32896496)
9. S.E. Jones A new estrogen receptor antagonist-an overview of available data Breast Cancer Res Tr 75 2002 S19 S21
10. A.S. Bhatnagar Review of the development of letrozole and its use in advanced breast cancer and in the neoadjuvant setting The Breast 15 2006 S3 S13
11. C.L. Vogel Hormonal approaches to breast cancer treatment and prevention: an overview Semin Oncol 23 1996 2 9 (Pubitemid 26320221)
12. R.J. Santen, A. Manni, H. Harvey, and C. Redmond Endocrine treatment of breast cancer in women Endocr Rev 11 1990 221 265 (Pubitemid 20182870)
13. V.C. Jordan Tamoxifen: a most unlikely pioneering medicine Nat Rev Drug Discov 2 2003 205 213 (Pubitemid 37361665)
14. G.P. Perdue, R.N. Blomster, D.A. Blake, and N.R. Farnsworth South American plants II: taspine isolation and anti-inflammatory activity J Pharm Sci 68 1979 124 126 (Pubitemid 9100643)
15. L. Pieters, T. De Bruyne, M. Claeys, A. Vlietinck, M. Calomme, and B.D. Vanden Isolation of a dihydrobenzofura lignan from South American Dragon's Blood (Croton Spp.) as an inhibitor of cell proliferation J Nat Prod 56 1993 899 906 (Pubitemid 23195618)
16. D.J. Milanowski, R.E. Winter, Elv in-Lewis, M.P. Lewis, and W.H. Lewis Geographic distribution of three alkaloid chemotypes of Croton lechleri J Nat Prod 65 2002 814 819 (Pubitemid 34733982)
17. E. Risco, F. Ghia, R. Vila, J. Iglesias, E. Alvarez, and S. Canigueral Immunomodulatory activity and chemical characterisation of sangre de drago (dragon's blood) from Croton lechleri Planta Med 69 2003 785 794 (Pubitemid 37346563)
18. E.J. Kennelly, T.J. Flynn, E.P. Mazzola, J.A. Roach, T.G. McCloud, and D.E. Danford Detecting potential teratogenic alkaloids from blue cohosh rhizomes using an in vitro rat embryo culture J Nat Prod 62 1999 1385 1389 (Pubitemid 29504100)
19. J.M. Rollinger, D. Schuster, E. Baier, E.P. Ellmerer, T. Langer, and H. Stuppner Taspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana J Nat Prod 69 2006 1341 1346 (Pubitemid 44568245)
20. Y.P. Li, and L.C. He Establishing and preliminary application of vascular endothelial cell membrane chromatography Chin Sci Bull 52 2007 410 415
21. B.H. Porras-Reyes, W.H. Lewis, J. Roman, L. Simchowitz, and T.A. Mustoe Enhancement of wound healing by the alkaloid taspine defining mechanism of action Proc Soc Exp Biol Med 203 1993 18 25 (Pubitemid 23122013)
22. H. Itokawa, Y. Ichihara, M. Mochizuki, T. Enomori, H. Morita, and O. Shirota A cytotoxic substance from Sangre de Grado Chem Pharm Bull 39 1991 1041 1042
23. W. Fayad, M. Fryknäs, S. Brnjic, M.H. Olofsson, R. Larsson, and S. Linder Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters Plos one 10 2009 e7238
24. 180 sarcoma and its mechanism Zhongguo Zhong Yao Za Zhi 32 2007 27 30
25. P. Wu, X.H. Wang, F. Li, B.J. Qi, H. Zhu, and S. Liu Growth suppression of MCF-7 cancer cell-derived xenografts in nude mice by caveolin-1 Biochem Biophys Res Commun 376 2008 215 220
26. J.Y. Im, H. Park, K.W. Kang, W.S. Choi, and H.S. Kim Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells Chem Biol Interact 172 2008 235 244
27. Q.N. Li, L.Y. Wu, D.K. Oelschlager, M. Wan, C.R. Stockard, and W.E. Grizzle Smad4 inhibits tumor growth by inducing apoptosis in estrogen receptor-positive breast cancer cells J Biol Chem 280 2005 27022 27028 (Pubitemid 41043225)
28. S. Salami, and K.T. Fatemeh Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines Clin Biochem 36 2003 247 253 (Pubitemid 36694969)
29. I.T. Nizamutdinova, G.W. Lee, K.H. Son, S.J. Jeon, S.S. Kang, and Y.S. Kim Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells Int J Oncol 33 2008 485 491
30. L.A. Helguero, M.H. Faulds, J.A. Gustafsson, and L.A. Haldose Estrogen receptors alfa (ERα) and beta (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11 Oncogene 24 2005 6605 6616 (Pubitemid 41486791)
31. Y.M. Zhang, L.C. He, L. Meng, and W.J. Luo Taspine isolated from Radix et Rhizoma Leonticis inhibits proliferation and migration of endothelial cells as well as chicken chorioallantoic membrane neovascularisation Vasc Pharmacol 48 2008 129 137
32. Y.M. Zhang, L.C. He, and Y.L. Zhou Taspine isolated from Radix et Rhizoma Leonticis inhibits growth of human umbilical vein endothelial cell (HUVEC) by inducing its apoptosis Phytomedicine 15 2008 112 119
33. J.F. Herr, A.H. Wyllie, and A.R. Currie Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 26 1972 239 257
34. A. Degterev, M. Boyce, and J. Yuan A decade of caspases Oncogene 22 2003 8543 8567 (Pubitemid 38028527)
35. D.A. Carson, and J.M. Ribeiro Apoptosis and disease Lancet 341 1993 1251 1254 (Pubitemid 23146938)
36. S.M. Mikulski Pathogenesis of cancer in view of mutually opposing apoptotic and anti-apoptotic growth signals Intl J Oncol 4 1994 1257 1263 (Pubitemid 24180327)
37. C.G. Tepper, S. Jayadev, B. Liu, A. Bielawska, R. Wolff, and S. Yonehara Role for ceramide as an endogenous mediator of fas-induced cytotoxicity Proc Natl Acad Sci U S A 92 1995 8443 8447
38. D.E. Morales, K.A. McGowan, D.S. Grant, S. Maheshwari, D. Bhartiya, and M.C. Cid Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model Circulation 91 1995 755 763
39. M.C. Cid, H.K. Kleinman, D.S. Grant, H.W. Schnaper, A.S. Fauci, and G.S. Hoffman Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1 J Clin Invest 93 1994 17 25
40. A. Gompel, S. Somai, M. Chaouat, A. Kazem, H.J. Kloosterboer, and I. Beusman Hormonal regulation of apoptosis in breast cells and tissues Steroids 65 2000 593 598
41. L.S. Wang, Y.W. Huang, S.L. Liu, P. Yan, and Y.C. Lin Conjugated linoleic acid induces apoptosis through estrogen receptor alpha in human breast tissue BMC Cancer 8 2008 208
42. I. Spyridopoulos, A.B. Sullivan, M. Kearney, J.M. Isner, and D.W. Losordo Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis Circulation 95 1997 1505 1514 (Pubitemid 27142809)